Skip to main content

Growth

0
Pipeline Programs
3
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
3 programs
Control Infant FormulaN/A1 trial
Control ProductN/A1 trial
Experimental Infant FormulaN/A1 trial
Active Trials
NCT04957992Completed607Est. May 2025
NCT05551975Not Yet Recruiting321Est. Jan 2028
NCT03276884Completed267Est. Nov 2018
Alliance Pharmaceuticals
1 program
Eggs plus standard of careN/A1 trial
Active Trials
NCT04316221Completed1,200Est. Sep 2023
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
How Infant Diets Would Affect Growth in Early ChildhoodN/A1 trial
Active Trials
NCT02440503Completed75Est. Aug 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
AbbottControl Product
AbbottControl Infant Formula
Alliance PharmaceuticalsEggs plus standard of care
AbbottExperimental Infant Formula
Colorado TherapeuticsHow Infant Diets Would Affect Growth in Early Childhood

Clinical Trials (5)

Total enrollment: 2,470 patients across 5 trials

NCT05551975AbbottControl Product

Preterm Infants Fed a Human Milk Fortifier

Start: Sep 2024Est. completion: Jan 2028321 patients
N/ANot Yet Recruiting
NCT04957992AbbottControl Infant Formula

BIG Study (Brain, Immune, and Gut Health Evaluation of Infants/Young Children Fed Infant Formula, and Later Supplemental Toddler Nutrition, With 5 Specific HMOs)

Start: Jul 2021Est. completion: May 2025607 patients
N/ACompleted
NCT04316221Alliance PharmaceuticalsEggs plus standard of care

Effects of Complementary Feeding of Eggs on Infant Development and Growth in Guatemala: The Saqmolo Study

Start: Apr 2021Est. completion: Sep 20231,200 patients
N/ACompleted
NCT03276884AbbottExperimental Infant Formula

Growth and Tolerance of Young Infants

Start: Oct 2017Est. completion: Nov 2018267 patients
N/ACompleted
NCT02440503Colorado TherapeuticsHow Infant Diets Would Affect Growth in Early Childhood

How Infant Diets Would Affect Growth in Early Childhood

Start: Jun 2014Est. completion: Aug 201775 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.